Skip to main content
. 2020 Mar 14;12(3):e7269. doi: 10.7759/cureus.7269

Figure 2. PREDICT and Nottingham prognostic index (NPI) scores for patients selected for Oncotype DX (ODX) testing compared to patients not genetically profiled.

Figure 2

A) Median PREDICT score for patients in the ODX and non-ODX groups (Mann-Whitney, P<0.0001); B) proportion of low, intermediate, or high PREDICT scores for patients in the ODX and non-ODX groups (chi-squared, P<0.0001); C) median NPI score for patients in the ODX and non-ODX groups (Mann-Whitney, P<0.0001 ); and D) proportion of excellent, good, moderate, or poor NPI scores for patients in the ODX and non-ODX groups (chi-squared, P<0.0001); ODX group, patients with cancers that were genetically profiled through Oncotype DX testing; non-ODX group, patients that did not have Oncotype DX testing; for patients with multifocal disease, the highest PREDICT or NPI score was used.